PMID- 30954629 OWN - NLM STAT- MEDLINE DCOM- 20200323 LR - 20200323 IS - 1096-1186 (Electronic) IS - 1043-6618 (Linking) VI - 144 DP - 2019 Jun TI - Complex regulation of ecto-5'-nucleotidase/CD73 and A(2A)R-mediated adenosine signaling at neurovascular unit: A link between acute and chronic neuroinflammation. PG - 99-115 LID - S1043-6618(18)31909-1 [pii] LID - 10.1016/j.phrs.2019.04.007 [doi] AB - The review summarizes available data regarding the complex regulation of CD73 at the neurovascular unit (NVU) during neuroinflammation. Based on available data we propose the biphasic pattern of CD73 regulation at NVU, with an early attenuation and a postponed up-regulation of CD73 activity. Transient attenuation of CD73 activity on leukocyte/vascular endothelium and leukocyte/astrocyte surface, required for the initiation of a neuroinflammatory response, may be effectuated either by catalytic inhibition of CD73 and/or by shedding of the CD73 molecule from the cell surface, while postponed induction of CD73 is effectuated by transcriptional up-regulation of Nt5e and posttranslational modifications. Neuroinflammatory conditions are also associated with significant enhancement and gain-of-function of A(2A)R-mediated adenosine signaling. However, in contrast to the temporary prevalence of A(2A)R over A(1)R signaling during an acute inflammatory response, prolonged induction of A(2A)R and resulting perpetual CD73/A(2A)R coupling may be a contributing factors in the transition between acute and chronic neuroinflammation. Thus, pharmacological targeting of the CD73/A(2A)R axis may attenuate inflammatory response and ameliorate neurological deficits in chronic neuroinflammatory conditions. CI - Copyright (c) 2019 Elsevier Ltd. All rights reserved. FAU - Nedeljkovic, Nadezda AU - Nedeljkovic N AD - Department of General Physiology and Biophysics, Faculty of Biology University of Belgrade, Studentski trg 3, Belgrade 11001, Serbia. Electronic address: nnedel@bio.bg.ac.rs. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20190405 PL - Netherlands TA - Pharmacol Res JT - Pharmacological research JID - 8907422 RN - 0 (GPI-Linked Proteins) RN - 0 (Receptor, Adenosine A2A) RN - EC 3.1.3.5 (5'-Nucleotidase) RN - EC 3.1.3.5 (NT5E protein, human) RN - K72T3FS567 (Adenosine) SB - IM MH - 5'-Nucleotidase/*immunology MH - Adenosine/*immunology MH - Animals MH - Chronic Disease MH - GPI-Linked Proteins/immunology MH - Humans MH - Inflammation/*immunology MH - Nervous System Diseases/immunology MH - *Neurovascular Coupling MH - Receptor, Adenosine A2A/*immunology MH - Signal Transduction OTO - NOTNLM OT - A(1)R OT - A(2A)R OT - Adenosine OT - Astrocytes OT - Chronic neuroinflammation OT - Ecto-5'-nucleotidase/CD73 EDAT- 2019/04/08 06:00 MHDA- 2020/03/24 06:00 CRDT- 2019/04/08 06:00 PHST- 2018/11/29 00:00 [received] PHST- 2019/04/01 00:00 [revised] PHST- 2019/04/03 00:00 [accepted] PHST- 2019/04/08 06:00 [pubmed] PHST- 2020/03/24 06:00 [medline] PHST- 2019/04/08 06:00 [entrez] AID - S1043-6618(18)31909-1 [pii] AID - 10.1016/j.phrs.2019.04.007 [doi] PST - ppublish SO - Pharmacol Res. 2019 Jun;144:99-115. doi: 10.1016/j.phrs.2019.04.007. Epub 2019 Apr 5.